Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Pink

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Molecular Cancer Research : MCR|November 10, 2017
Loss of Uracil DNA Glycosylase Selectively Resensitizes p53-Mutant and -Deficient Cells to 5-FdUYan Yan, Yulan Qing, John J Pink, et al.
Journal of Biomedical Materials Research. Part A|April 5, 2005
Interactions between self-assembled polyelectrolyte shells and tumor cellsHua Ai, John J Pink, Xintao Shuai, et al.
Cancer Biology & Therapy|May 17, 2003
Mu-calpain activation in beta-lapachone-mediated apoptosisColleen Tagliarino, John J Pink, Kathryn E Reinicke, et al.
European Journal of Medicinal Chemistry|November 29, 2011
From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluationBo Zhong, Xiaohan Cai, Snigdha Chennamaneni, et al.
Journal of Medicinal Chemistry|June 18, 2013
Synthesis and anticancer mechanism investigation of dual Hsp27 and tubulin inhibitorsBo Zhong, Snigdha Chennamaneni, Rati Lama, et al.
Journal of Medicinal Chemistry|March 23, 2012
Identification of a class of novel tubulin inhibitorsXin Yi, Bo Zhong, Kerri M Smith, et al.
The Journal of Investigative Dermatology|January 8, 2021
Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in MelanomaWesley Y Yu, Sheena T Hill, E Ricky Chan, et al.
Cancer Biology & Therapy|August 7, 2009
The C-terminus of interferon gamma receptor beta chain (IFNgammaR2) has antiapoptotic activity as a Bax inhibitorJose A Gomez, Weiyon Sun, Vivian Gama, et al.
British Journal of Cancer|August 26, 2016
MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft modelC Marcela Diaz-Montero, Frances J Mao, John Barnard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed-Platinum-Radiation in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: Results of a Phase I TrialTithi Biswas, Afshin Dowlati, Charles A Kunos, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecular Cancer Research : MCR|November 10, 2017
Loss of Uracil DNA Glycosylase Selectively Resensitizes p53-Mutant and -Deficient Cells to 5-FdUYan Yan, Yulan Qing, John J Pink, et al.
Journal of Biomedical Materials Research. Part A|April 5, 2005
Interactions between self-assembled polyelectrolyte shells and tumor cellsHua Ai, John J Pink, Xintao Shuai, et al.
Cancer Biology & Therapy|May 17, 2003
Mu-calpain activation in beta-lapachone-mediated apoptosisColleen Tagliarino, John J Pink, Kathryn E Reinicke, et al.
European Journal of Medicinal Chemistry|November 29, 2011
From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluationBo Zhong, Xiaohan Cai, Snigdha Chennamaneni, et al.
Journal of Medicinal Chemistry|June 18, 2013
Synthesis and anticancer mechanism investigation of dual Hsp27 and tubulin inhibitorsBo Zhong, Snigdha Chennamaneni, Rati Lama, et al.
Journal of Medicinal Chemistry|March 23, 2012
Identification of a class of novel tubulin inhibitorsXin Yi, Bo Zhong, Kerri M Smith, et al.
The Journal of Investigative Dermatology|January 8, 2021
Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in MelanomaWesley Y Yu, Sheena T Hill, E Ricky Chan, et al.
Cancer Biology & Therapy|August 7, 2009
The C-terminus of interferon gamma receptor beta chain (IFNgammaR2) has antiapoptotic activity as a Bax inhibitorJose A Gomez, Weiyon Sun, Vivian Gama, et al.
British Journal of Cancer|August 26, 2016
MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft modelC Marcela Diaz-Montero, Frances J Mao, John Barnard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed-Platinum-Radiation in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: Results of a Phase I TrialTithi Biswas, Afshin Dowlati, Charles A Kunos, et al.
Pageof 2